about
SORL1 Gene is Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's DiseaseImpact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation.A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects.Serotonin toxicity: a short review of the literature and two case reports involving citalopram.Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer disease.Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory.Cognitive interventions targeting subjective cognitive complaints.Familial Alzheimer's disease sustained by presenilin 2 mutations: systematic review of literature and genotype-phenotype correlation.Contribution of right hemisphere to visual imagery: a visual working memory impairment?Cognitive reserve and the risk for Alzheimer's disease: a longitudinal study.Mild behavioral impairment: Ethical, methodological and clinical reflections.Determinants of societal costs in Alzheimer's disease: GERAS study baseline results.A novel mutation in the predicted TMIII domain of the PSEN2 gene in an Italian pedigree with atypical Alzheimer's disease.Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.Efficacy of sertraline in a patient with Neuro-Beçhet's disease.Effect of citalopram in treating hypersexuality in an Alzheimer's disease case.Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study.Rivastigmine in the treatment of hypersexuality in Alzheimer disease.Analysis of burden in caregivers of people with Alzheimer's disease using self-report and supervision hours.Neuropsychological predictors of rapidly progressive Alzheimer's disease.A case-control study on Alzheimer's disease and exposure to anesthesia.Binge eating and fast cognitive worsening in an early-onset bvFTD patient carrying C9ORF72 expansion.Causes of cross-over in unilateral neglect: between-group comparisons, within-patient dissociations and eye movements.Restless legs syndrome in a group of patients with Alzheimer's disease.Prosodic impairment in Alzheimer's disease: assessment and clinical relevance.The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.Issues about the use of subjective cognitive decline in Alzheimer's disease research.The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease.A descriptive study on constructional impairment in frontotemporal dementia and Alzheimer's disease.Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial.Replication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer's disease patients.Increased levels of acute-phase inflammatory proteins in plasma of patients with sporadic CJD.Presenilin 2 mutation R71W in an Italian early-onset sporadic Alzheimer's disease case.Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's diseaseActivation of Tyrosine Phosphorylation Signaling in Erythrocytes of Patients with Alzheimer's Disease
P50
Q28260619-6D9835AD-33D4-41E3-B62E-4BD4F0DCA352Q30600808-03BD91B6-E835-441D-BBC9-AE057345BE75Q34615259-C5049021-6209-40F8-9F43-1C9044D7E41FQ37596887-FAB3D9F4-89F4-4D3A-8BD4-A1B478686A3EQ37864955-60158677-DC59-421D-8E7D-A5FECE8FFF72Q37953208-F017746D-00FA-4A4F-9B7B-52A621165951Q38059401-90B94B95-DD29-434E-830C-954277E53BE7Q38119056-42CAD15C-129C-4178-84B4-8343B9AA9B67Q38193247-BAD4E7D1-51B2-4FE8-BCCD-DB1A5E875241Q38387382-1B6570AE-3334-4DF3-BA53-7E78402DCF6DQ39092729-9F341C40-E13F-44BB-931D-D75F64D47BE6Q40603858-08A7D1C0-DF9A-4A67-8F08-A3582526E2F9Q41110780-7FE10107-11F0-49F5-B088-3654E8417B00Q43158570-1BC7198E-D9EC-4769-A29A-DD36A30B4DF0Q44116778-2BC6CBC2-F895-476C-8878-82657BADFFDFQ44120519-52FFAAD2-2D96-4C08-BD99-44562CF59FA3Q46352085-1A06B7DA-64D3-4972-A797-296EFE2D7E3BQ46742474-2DADDDC5-2703-44E3-BB08-470C4ABC1ECAQ46764929-13380C67-F4D8-47BA-A234-EB1ACF398438Q48212308-D37059B6-D4B0-4B6B-BC5F-8EC8BA133BD3Q48215502-BCE08E0C-184F-4C42-B54C-E819DB2FAF5EQ48553888-D890FC2D-0769-4B1C-831D-DFFE74F238C0Q48584051-A1305CB2-DB90-46A2-8C0B-97CBD1B479AAQ48975307-B79916BC-F550-4F27-94C5-66604D12DCBCQ50543938-87D770B4-68C6-4161-BC52-590EB7F898B8Q50623876-3B4683D4-F1D1-49CD-A32C-4D9A8D8021EEQ50711864-A9E68515-75F3-49AD-963A-CDA14196E2B8Q50779388-151DFF8A-26C6-4181-8B81-AB813F45A973Q51051434-6FFAAE88-CAF9-423A-AFFC-19DE218450B4Q51965534-19C2F8BD-2051-4BE6-8512-99D83B0A4943Q53319378-061B1585-470C-49F3-969F-4094D4511610Q53327478-3D0C986B-A5F0-4292-B4FC-001465C244BFQ53331274-3B0FA294-3C73-4F49-A6E0-7A3138A8EBE6Q53424564-43BEE1A3-6459-440B-95DC-A996FCD1933DQ57746661-9B9CB0BE-0429-4B09-A021-2B0DB25B5484Q90198188-EB2CE08B-0BE5-4097-B771-F06F90BBE09C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore (neuroscienze)
@it
հետազոտող
@hy
name
Giuseppe Bruno
@ast
Giuseppe Bruno
@en
Giuseppe Bruno
@es
Giuseppe Bruno
@it
Giuseppe Bruno
@nl
Giuseppe Bruno
@sl
Джузеппе Бруно
@ru
type
label
Giuseppe Bruno
@ast
Giuseppe Bruno
@en
Giuseppe Bruno
@es
Giuseppe Bruno
@it
Giuseppe Bruno
@nl
Giuseppe Bruno
@sl
Джузеппе Бруно
@ru
prefLabel
Giuseppe Bruno
@ast
Giuseppe Bruno
@en
Giuseppe Bruno
@es
Giuseppe Bruno
@it
Giuseppe Bruno
@nl
Giuseppe Bruno
@sl
Джузеппе Бруно
@ru
P106
P1153
7202705363
P21
P31
P496
0000-0001-6948-7169